Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs

  • M. Golam Mohi
  • , Christina Boulton
  • , Ting Lei Gu
  • , David W. Sternberg
  • , Donna Neuberg
  • , James D. Griffin
  • , D. Gary Gilliland
  • , Benjamin G. Neel

Research output: Contribution to journal › Article › peer-review

234 Scopus citations

Fingerprint

Dive into the research topics of 'Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience